Swipe om te navigeren naar een ander artikel
Schizophrenia-related impairments impact functional status and health-related quality of life. The Social Integration Survey (SIS) measures social functioning outcomes in schizophrenia from patient and informant perspectives.
A total of 129 patient/informant dyads at eight US sites participated. Patients were at least 18 years old, with schizophrenia or schizoaffective disorder for 1 year or more, residing in the community. Informants were at least 21 years old, cared for patient at least 1 month, with contact at least twice weekly. The SIS, PSP, PETiT, QLS, CGI-S, and PANSS were completed. Individual item performance, subscale development, reliability, and validity were examined.
Items were easily understood and responses well-distributed for patients and informants. Four of five subscales identified were internally consistent (alphas ≥0.68) and stable over time. Inter-rater reliability was low. SIS scores were not strongly correlated with other measures, except PETiT Quality of Life. The SIS differentiated on social functioning at varying levels of symptom severity (P < 0.05).
Patient and informant-completed versions showed adequate internal consistency, test–retest reliability, and discriminant validity. Lack of correspondence between patient and informant responses and construct validity require further examination. Work-related items were inapplicable for most patients, but would be for those with higher functioning.
Log in om toegang te krijgen
Met onderstaand(e) abonnement(en) heeft u direct toegang:
National Institute of Mental Health (NIMH) (2001). When someone has schizophrenia. Retrieved October 10, 2006 from http://www.nimh.nih.gov/publicat/schizsoms.cfm#2.
World Health Organization (WHO) (2006). Schizophrenia. Retrieved October 9, 2006 from http://www.who.int/mental_health/management/schizophrenia/en/.
Ware, J. E., Snow, K. K., Kosinski, M. K., & Gandek, B. (1993). SF-36 health survey: Manual and interpretation guide. Boston, MA: The Health Institute, New England Medical Center.
Ware, J. E., Kosinski, M., & Dewey, J. E. (2000). How to score version 2 of the SF-36 health survey. Lincoln, RI: QualityMetric
The World Health Organization Quality of Life (WHOQOL) Group. (1998). The world health organization quality of life assessment (WHOQOL): Development and general psychometric properties. Social Science & Medicine, 46(12), 1569–1585. CrossRef
WHOQOL Group. (1998). Development of the world health organization WHOQOL-BREF quality of life assessment. Psychological Medicine, 28(3), 551–558. CrossRef
Revicki, D. A., Genduso, L. A., Hamilton, S. H., Ganoczy, D., & Beasley, C. M. (1999). Olanzapine versus haloperidol in the treatment of schizophrenia and other psychotic disorders: Quality of life and clinical outcomes for a randomized clinical trial. Quality of Life Research, 8(5), 417–426. PubMedCrossRef
Strauss, J. S., & Carpenter, W. T., Jr. (1977). Prediction of outcome in schizophrenia. III. Five-year outcome and its predictors. Archives of General Psychiatry, 34(2), 159–163. PubMed
Heinrichs, D. W., Hanlon, T. E., & Carpenter, W. T., Jr. (1984). The quality of life scale: An instrument for rating the schizophrenic deficit syndrome. Schizophrenia Bulletin, 10(3), 388–398. PubMed
Cramer, J. A., Rosenheck, R., Xu, W., Thomas, J., Henderson, W., & Charney, D. S. (2000). Quality of life in schizophrenia: A comparison of instruments. Department of veterans affairs cooperative study group on clozapine in refractory schizophrenia. Schizophrenia Bulletin, 26(3), 659–666. PubMed
Martin, C. R., & Allan, R. (2007). Factor structure of the schizophrenia quality of life scale revision 4 (SQLS-R4). Psychology, Health & Medicine, 12(2), 126–134.
Martin, P., Caci, H., Azorin, J. M., Dalery, J., Hardy-Bayle, M. C., Etienne, D., et al. (2005). Groupe d’etude SOL. A new patient focused scale for measuring quality of life in schizophrenic patients: the schizophrenia quality of life scale (SOL). Encephale, 31(5, Pt. 1), 559–566.
Oliver, J., Huxley, P., Bridges, K., & Mohamed, H. (Eds.). (1996). Quality of life and mental health services. London: Routledge.
Gaite, L., Vázquez-Barquero, J. L., Arriaga Arrizabalaga, A., Schene, A. H., Welcher, B., Thornicroft, G., et al. (2000). Quality of life in schizophrenia: Development, reliability and internal consistency of the lancashire quality of life profile—European version. EPSILON study 8. European psychiatric services: Inputs linked to outcome domains and needs. British Journal of Psychiatry, 177(Suppl. 39), S49–S54. CrossRef
Lehman, A. F., Fischer, E. P., Postrado, L., Delahanty, J., Johnstone, B. M., Russo, P. A., et al. (2003). The schizophrenia care and assessment program health questionnaire (SCAP-HQ): An instrument to assess outcomes of schizophrenia care. Schizophrenia Bulletin, 29(2), 247–256. PubMed
Patterson, T. L., Goldman, S., McKibbin, C. L., Hughs, T., & Jeste, D. V. (2001). UCSD performance-based skills assessment: Development of a new measure of everyday functioning for severely mentally ill adults. Schizophrenia Bulletin, 27(2), 235–245. PubMed
Bell, M. D., & Bryson, G. (2001). Work rehabilitation in schizophrenia: Does cognitive impairment limit improvement? Schizophrenia Bulletin, 27(2), 269–279. PubMed
Gaite, L., Vázquez-Barquero, J. L., Borra, C., Ballesteros, J., Schene, A., Welcher, B., et al. (2002). EPSILON Study Group. Quality of life in patients with schizophrenia in five European countries: The EPSILON study. Acta Psychiatrica Scandinavica, 105(4), 283–292.
Green, M. F., Kern, R. S., Braff, D. L., & Mintz, J. (2000). Neurocognitive deficits and functional outcome in schizophrenia: Are we measuring the “right stuff”? Schizophrenia Bulletin, 26(1), 119–136. PubMed
American Psychiatric Association (APA). (2000). Diagnostic and statistical manual of mental disorders, 4th ed., text revision. Washington, DC: American Psychiatric Press.
Morosini, P. L., Magliano, L., Brambilla, L., Ugolini, S., & Pioli, R. (2000). Development, reliability and acceptability of a new version of the DSM-IV social and occupational functioning assessment scale (SOFAS) to assess routine social functioning. Acta Psychiatrica Scandinavica, 101(4), 323–329. PubMed
Vorunganti, L., & Awad, A. (2002). Personal evaluation of transitions in treatment (PETiT): A scale to measure subjective aspects of antipsychotic drug therapy in schizophrenia. Schizophrenia Research, 56(1–2), 37–46. CrossRef
Guy, W. (1976). The clinical global impression scale. In ECDEU assessment manual for psychopharmacology, Revised. Rockville, MD: National Institute for Mental Health.
Kay, S., Fiszbein, A., & Opler, L. (1987). The positive and negative syndrome scales (PANSS) for schizophrenia. Schizophrenia Bulletin, 13(2), 261–276. PubMed
SAS Institute. (2002–2003). SAS software, version 9.1. Cary, NC: SAS Institute.
Thissen, D., Chen, W. H., & Bock, D. (2002). MULTILOG. Lincolnwood, IL: Scientific Software International.
Samejima, F. (1969). Estimation of latent trait ability using a response pattern of graded scores. Psychometrika Monographs, 34(4, Pt. 2), Whole No. 17.
Deyo, R. A., Diehr, P., & Patrick, D. L. (1991). Reproducibility and responsiveness of health status measures. Statistics and strategies for evaluation. Controlled Clinical Trials, 12(4, Suppl. 1), S142–S158. CrossRef
Hays, R. D., & Revicki, D. A. (2005). Reliability and validity, including responsiveness. In P. Fayers , & R. D. Hays (Eds.), Assessing quality of life in clinical trials, second edition. New York: Oxford University Press.
- Reliability and validity of the social integration survey (SIS) in patients with schizophrenia
Ariane K. Kawata
Dennis A. Revicki
- Springer Netherlands